A
Aeglea BioTherapeutics
0 followers
Aeglea BioTherapeutics is a clinical-stage biotechnology company redefining the potential of human enzyme therapeutics to benefit people with rare and devastating metabolic diseases with limited treatment options.
Org chart
Russell J. Cox
Chief Executive Officer, Epirium Bio
Russell J. Cox
Collapse
Cortney Caudill
Chief Product Officer
Eric Bradford
Chief Development Officer
Gillian Bubb
Senior Director Clinical Science, Clinical Development. Rare Genetic Disease
Board & advisors
Russell J. Cox
Director
Hunter C. Smith
Director
Michael Henderson
Director
Peter Harwin
Director
Tomas Kiselak
Director
Teams
Offices
Similar companies
Sutro Biopharma
3 followers
Active Motif
3 followers
Dyno Therapeutics
4 followers
Janux Therapeutics
1 follower
Eikon Therapeutics
1 follower
Gilead Sciences
140 followers
Regeneron
106 followers
Illumina
74 followers
Agilent Technologies
74 followers
Verily Life Sciences
39 followers
Alexion Pharmaceuticals
35 followers
Explore companies